We serve Chemical Name:3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride CAS:1228552-93-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride
CAS.NO:1228552-93-9
Synonyms:3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride
Molecular Formula:C5H10ClN5O
Molecular Weight:191.61900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:87.90000
Exact Mass:191.05700
LogP:0.47190
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride Use and application,3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride technical grade,usp/ep/jp grade.
Related News: Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. 3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride supplier Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride vendor Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 3-Amino-N,N-dimethyl-1H-1,2,4-triazole-5-carboxamide hydrochloride factory First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.
